HK1019734A1 - Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases - Google Patents

Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases

Info

Publication number
HK1019734A1
HK1019734A1 HK99102910A HK99102910A HK1019734A1 HK 1019734 A1 HK1019734 A1 HK 1019734A1 HK 99102910 A HK99102910 A HK 99102910A HK 99102910 A HK99102910 A HK 99102910A HK 1019734 A1 HK1019734 A1 HK 1019734A1
Authority
HK
Hong Kong
Prior art keywords
benzimidazol
piperidin
aryl
butyl
amino
Prior art date
Application number
HK99102910A
Other languages
English (en)
Inventor
George Daniel Maynard
John Michael Kane
Elizabeth Mary Kudlacz
Christopher Robin Dalton
Braulio Santiago
Larry Don Bratton
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/778,996 external-priority patent/US5922737A/en
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1019734A1 publication Critical patent/HK1019734A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK99102910A 1996-02-21 1999-07-07 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases HK1019734A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60421696A 1996-02-21 1996-02-21
US08/778,996 US5922737A (en) 1996-02-21 1997-01-06 Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
PCT/US1997/001571 WO1997030989A1 (en) 1996-02-21 1997-01-29 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases

Publications (1)

Publication Number Publication Date
HK1019734A1 true HK1019734A1 (en) 2000-02-25

Family

ID=27084615

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102910A HK1019734A1 (en) 1996-02-21 1999-07-07 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases

Country Status (20)

Country Link
EP (1) EP0888336B1 (ko)
JP (1) JP2001504798A (ko)
KR (1) KR19990087131A (ko)
CN (1) CN1115341C (ko)
AR (1) AR005896A1 (ko)
AT (1) ATE221882T1 (ko)
AU (1) AU710488B2 (ko)
BR (1) BR9707652A (ko)
CA (1) CA2247105C (ko)
DE (1) DE69714579T2 (ko)
DK (1) DK0888336T3 (ko)
ES (1) ES2176687T3 (ko)
HK (1) HK1019734A1 (ko)
HU (1) HUP9901030A3 (ko)
IL (1) IL125578A (ko)
NO (1) NO983830L (ko)
NZ (1) NZ330908A (ko)
PT (1) PT888336E (ko)
TW (1) TW562804B (ko)
WO (1) WO1997030989A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
GB0315203D0 (en) * 2003-06-28 2003-08-06 Celltech R&D Ltd Chemical compounds
EP2129381A1 (en) 2007-01-24 2009-12-09 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
CN1067385C (zh) * 1994-08-25 2001-06-20 默里尔药物公司 用于治疗变应性疾病的新的取代的哌啶类化合物

Also Published As

Publication number Publication date
AU2251997A (en) 1997-09-10
CN1211246A (zh) 1999-03-17
JP2001504798A (ja) 2001-04-10
WO1997030989A1 (en) 1997-08-28
CA2247105C (en) 2002-05-14
TW562804B (en) 2003-11-21
CA2247105A1 (en) 1997-08-28
HUP9901030A3 (en) 2002-01-28
BR9707652A (pt) 1999-07-27
NZ330908A (en) 2001-04-27
DE69714579D1 (de) 2002-09-12
DE69714579T2 (de) 2003-04-10
AR005896A1 (es) 1999-07-21
AU710488B2 (en) 1999-09-23
KR19990087131A (ko) 1999-12-15
NO983830D0 (no) 1998-08-20
DK0888336T3 (da) 2002-12-02
HUP9901030A2 (hu) 1999-07-28
NO983830L (no) 1998-10-20
PT888336E (pt) 2002-12-31
EP0888336A1 (en) 1999-01-07
IL125578A0 (en) 1999-03-12
IL125578A (en) 2002-09-12
CN1115341C (zh) 2003-07-23
EP0888336B1 (en) 2002-08-07
ES2176687T3 (es) 2002-12-01
ATE221882T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
HUP0102367A3 (en) Benzamide derivatives for the treatment of diseases mediated by cytokines
DE69903543T2 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69528011D1 (de) Verfahren zur Pflege der Nägel
EE9900036A (et) Uued ühendid ja kompositsioonid trüptaasi aktiivsusega seotud haiguste raviks
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
HUP9901751A3 (en) Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
HK1019734A1 (en) Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
NO994258L (no) Anvendelse av levobupivakain for behandling av ansiktsmigrene
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
IL125605A0 (en) Novel substituted n-methyl-n-(4(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
HK1018956A1 (en) Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl benzamides useful for the treatment of allergic diseases
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
AU686084B3 (en) Pharmaceutical compositions for the treatment of depressive disorders
SI0888336T1 (en) Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
ZA971323B (en) Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin 1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases.
AU1393801A (en) Method for the treatment and/or prophylaxis of diseases caused by il-12
ZA969484B (en) Novel substituted 4-(1H-benzimidazol-2-yl-amino)- piperidines useful for the treatment of allergic diseases
ZA957033B (en) Novel substituted piperidines useful for the treatment of allergic diseases
ZA971413B (en) Novel substituted n-methyl-n-(4-(piperindin-1-yl)-2(aryl) butyl)benzamines useful for the treatment of allergic diseases.
DE69907685D1 (de) Verwendung von derivaten von tetrahydropyridinen oder (4-hydroxypiperidin)-butylazolen zur herstellung von präparaten zur schmerzbehandlung

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060129